Some of the institutions that participated in the Ankerronde includes Citigroup Global, Societe Generale, Goldman Sachs, Nippon India Mutual Fund, Sageone, Nuvama and Niveshaay Sambhav Fund, according to a circular uploaded on the BSE website.
According to the circular, the company has assigned 41.65.383 shares on RS 325 each to anchor investors, so that the transaction size is aggregated to RS 135.37 crore.
The IPO of RS 451-Crore would open on August 19 for subscription and ends on August 21. The price band is set at RS 309 to RS 325 per share.
The IPO is a mix of a new issue of shares with a value of a maximum of RS 175 Crore and an offer for sale (OFS) of a maximum of 85 Lakh shares with a value of RS 276.25 Crore.
The proceeds from the new issue will be used by GEM oromatics for reimbursement of debt and general business purposes. Gem-Aromaten is a manufacturer of specialist ingredients in India, including essential oils, aromachemicals and derivatives with added value, with more than two decades of experience. The customer portfolio includes names such as Colgate-Palmolive, Dabur, Patanjali, SH Kelkar, Rossari Biotech and Symrise. The company has three advanced production facilities in Uttar Pradesh, Dadra and Nagar Haveli and Gujarat. The turnover of gem aromatics from operations increased by 11.38 percent to RS 503.95 CRORE in tax 2025 of RS 452.45 Crore in the previous tax, and the profit increased by 6.55 percent to RS 53.38 crore for tax 2025 of RS 50.10 Crore in the previous financial year.
Motilal Oswal Investment Advisors is the only lead manager of the book and Kfin Technologies is the registrar of the offer.
#Gem #Aromatics #collects #Crore #Anker #investors #prior #IPO